Bradley Merrill Thompson, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, authored an article for LinkedIn, titled “FDA’s Dramatic Announcement of Apple’s Clearances: Is There a Level Playing Field at FDA?”

Following is an excerpt:

The Apple new product announcement yesterday included the revelation that FDA had just granted – in letters dated September 11 – two different “de novo decisions” in Apple’s favor. Apple Chief Operating Officer Jeff Williams announced at the company’s September 12 special event in Cupertino that Apple has received FDA clearance for both an atrial fibrillation-detecting algorithm and an ECG that will be built into the company's Series 4 Apple Watch.

The clearance letters – posted the FDA’s website – are dated September 11. What’s remarkable about them is that Apple apparently filed its ECG clearance application on August 14, 2018, and the Irregular Rhythm Notification Feature application on August 9, 2018.

For those who may not have background in a de novo request, these requests are for the first of a kind device and therefore typically take longer to clear than a follow-on device cleared through the 510(k) process. According to FDA’s performance goals negotiated as a part of the user fee agreement, for 510(k) submissions received in FY 2018, FDA’s goal for the average Total Time to Decision is 124 calendar days. In contrast, FDA’s goal with regard to reviewing de novo submissions is for FDA to “issue a decision within 150 FDA days of receipt of the submission for … 50% of de novo requests received in FY 2018.” To be clear, that means it’s expected that the other 50% will take longer than 150 days. FDA cleared not one but two Apple de novo reviews in about 30 days. That’s remarkable.

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.